Oct
31
2023
Analyst Assessment On Reviva Pharmaceuticals’ Positive Schizophrenia Trial Data – Sees More Than 200% Upside In Stock
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine sig …